[{"Assets_0_Q2_USD":67030000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1658000000.0,"NetIncomeLoss_1_Q2_USD":-176000000.0,"NetIncomeLoss_2_Q2_USD":944000000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":12000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1018000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1020000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1018000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1018000000.0,"StockholdersEquity_0_Q2_USD":17938000000.0,"EarningsPerShareBasic_1_Q2_USD":-0.24,"EarningsPerShareBasic_2_Q2_USD":0.8,"EarningsPerShareDiluted_1_Q2_USD":-0.24,"EarningsPerShareDiluted_2_Q2_USD":0.8,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180802"}]